PHASEBIO PHARMACEUTICALS INC (PHAS) Stock Analyst Earnings Estimates
NASDAQ:PHAS - Nasdaq - US7172241090 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.36M 252.24% | 320K -86.44% | 10.831M 3,284.69% | 4.756M -56.09% | 3.135M -34.08% | 22.604M 621.02% | 55.403M 145.10% | 138.506M 150.00% | |
| EBITDA YoY % growth | -39.57M -102.61% | -84.35M -113.17% | -105.569M -25.16% | -89.168M 15.54% | -116.215M -30.33% | -124.415M -7.06% | -99.173M 20.29% | -80.634M 18.69% | |
| EBIT YoY % growth | -39.74M -102.34% | -84.86M -113.54% | -107.362M -26.52% | -84.925M 20.90% | -67.44M 20.59% | -69.857M -3.58% | -74.311M -6.37% | -80.629M -8.50% | |
| Operating Margin | -1,683.90% | -26,518.75% | -991.25% | -1,785.64% | -2,151.21% | -309.05% | -134.13% | -58.21% | |
| EPS YoY % growth | -1.42 71.19% | -3.39 -138.73% | -3.03 10.62% | -1.24 59.21% | -1.25 -1.19% | -0.93 25.92% | -1.02 -10.16% | -1.15 -12.36% |
All data in USD
| Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.38 42.20% | -0.32 64.19% | -0.13 42.35% | -0.09 73.00% | -0.09 75.94% | -0.09 71.52% | -0.31 -130.77% | -0.28 -200.00% | -0.26 -177.78% | -0.20 -122.22% |
| Revenue Q2Q % growth | -100.00% | 3.06M 1,836.71% | -100.00% | -100.00% | -100.00% | 6.442M | 10.721M | 14.045M | 20.711M | |
| EBITDA Q2Q % growth | -27.027M 1.32% | -17.731M 41.47% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -22.745M 20.41% | -19.238M 40.04% | -6.426M 64.75% | -4.08M 83.88% | -4.08M 82.06% | -4.08M 78.79% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -0.34 43.33% | -0.32 | -0.02 | -7.01% |
| Q1 2022 Q2Q % growth | -0.23 73.56% | -0.68 | 0.45 | 66.06% |
| Q4 2021 Q2Q % growth | -0.90 12.62% | -0.60 | -0.30 | -50.57% |
| Q3 2021 Q2Q % growth | -0.66 23.26% | -0.62 | -0.04 | -6.78% |
| Q2 2021 Q2Q % growth | -0.60 38.78% | -0.47 | -0.13 | -27.88% |
| Q1 2021 Q2Q % growth | -0.87 -67.31% | -0.75 | -0.12 | -16.24% |
| Q4 2020 Q2Q % growth | -1.03 -164.10% | -0.72 | -0.31 | -43.23% |
| Q3 2020 Q2Q % growth | -0.86 -115.00% | -0.78 | -0.08 | -9.93% |
| Q2 2020 Q2Q % growth | -0.98 -196.97% | -0.53 | -0.45 | -84.77% |
| Q1 2020 Q2Q % growth | -0.52 -73.33% | -0.37 | -0.15 | -39.48% |
| Q4 2019 Q2Q % growth | -0.39 | -0.41 | 0.02 | 4.69% |
| Q3 2019 Q2Q % growth | -0.40 | -0.38 | -0.02 | -6.56% |
| Q2 2019 Q2Q % growth | -0.33 | -0.33 | 0.00 | -1.42% |
| Q1 2019 Q2Q % growth | -0.30 | -0.42 | 0.12 | 28.61% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | 208K -97.99% | 849.997K | -641.997K | -75.53% |
| Q1 2022 Q2Q % growth | 117K | 2.38M | -2.263M | -95.08% |
| Q4 2021 Q2Q % growth | 158K | 2.005M | -1.847M | -92.12% |
| Q3 2021 Q2Q % growth | 335K | 1.088M | -753K | -69.21% |
| Q2 2021 Q2Q % growth | 10.338M | 5.121M | 5.217M | 101.87% |
| Q1 2021 Q2Q % growth | -100.00% | 27.203K | -27.203K | -100.00% |
| Q4 2020 Q2Q % growth | -100.00% | 61.2K | -61.2K | -100.00% |
| Q3 2020 Q2Q % growth | -100.00% | 178.5K | -178.5K | -100.00% |
| Q2 2020 Q2Q % growth | -100.00% | 166.26K | -166.26K | -100.00% |
| Q1 2020 Q2Q % growth | 320K -50.77% | 2.255M | -1.935M | -85.81% |
| Q4 2019 Q2Q % growth | 760K | 252.705K | 507.295K | 200.75% |
| Q3 2019 Q2Q % growth | 240K | 230.265K | 9.735K | 4.23% |
| Q2 2019 Q2Q % growth | 700K | 168.3K | 531.7K | 315.92% |
| Q1 2019 Q2Q % growth | 650K | 40.8K | 609.2K | 1,493.14% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |